B-mode Ultrasound Imaging in Detecting Early Liver Cancer

Trial ID or NCT#

NCT02774161

Status

not recruiting iconNOT RECRUITING

Purpose

This pilot trial studies how well B-mode ultrasound imaging works in detecting liver cancer that is early in its growth and may not have spread to other parts of the body. Diagnostic procedures, such as B-mode ultrasound imaging, may help find and diagnose liver cancer and find out how far the disease has spread.

Official Title

Quantitative Ultrasound Spectroscopy to Early HCC

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. For Healthy Volunteers 1. Patients over 18 years of age. 2. Must have no known medical problems and have had a full medical exam within 6 months of the study. If healthy volunteers have not had a full medical exam within 6 months of the study, one of the ultrasound physicians will conduct the medical exam prior to any study procedures. For HCC patients 1. Patients over 18 years of age. 2. Patient with confirmed diagnosis of HCC, and untreated or Patients with Suspected HCC (Suspected HCC nodules should preferably be smaller than 3 cm and preferably within 6 cm in depth of the transducer head to minimize attenuation) and untreated or Patients at a higher risk of HCC undergoing a screening program by Ultrasound.
Exclusion Criteria:
  1. For Healthy volunteers 1. Patients who are not likely to comply with the protocol requirements. For HCC patients 1. Patients should not be taking other Investigational Agents. 2. Concomitant medications for treatment of the target lesion.

Investigator(s)

Aya Kamaya, MD
Aya Kamaya, MD
Radiologist
Professor of Radiology (Body Imaging)

Contact us to find out if this trial is right for you.

Contact

CCTO
650-498-7061